| Expanded Access Navigator

Read more about Assessment of Immunogenicity, Safety and Reactogenicity of a Booster Dose of Various COVID-19 Vaccine Platforms in Individuals Primed With Several Regimes.

Read more about Treatment Use of the CliniMACS® CD34 TCR Alpha/Beta for Allogenic Transplant (Expanded Access Use)

Read more about Digital Cognition Study During Long-COVID

Read more about Unleash the Mystery of COVID-19 Related Unusual Thrombosis

Read more about GlycoMimetics, Inc.

Read more about Resonance Breathing Training for Long Covid-related Myocardial Injury

Awards Nominations are now being accepted for the 2024 Innovations in Regulatory Science Awards. These awards will be presented at the Innovations in Regulatory Science Awards Gala on December 10, 2024 at the Willard InterContinental Hotel in Washington, DC.

Awards

Read more about Nominations Now Open for the 2024 Innovations in Regulatory Science Awards

Subscribe to

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

navigator@reaganudall.org

Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)

Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment

A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19

Assessment of Immunogenicity, Safety and Reactogenicity of a Booster Dose of Various COVID-19 Vaccine Platforms in Individuals Primed With Several Regimes.

Treatment Use of the CliniMACS® CD34 TCR Alpha/Beta for Allogenic Transplant (Expanded Access Use)

Digital Cognition Study During Long-COVID

Unleash the Mystery of COVID-19 Related Unusual Thrombosis

GlycoMimetics, Inc.

Resonance Breathing Training for Long Covid-related Myocardial Injury

Nominations Now Open for the 2024 Innovations in Regulatory Science Awards

Subscribe for updates from the Reagan-Udall Foundation for the FDA